Splenic hemangiopericytoma is a very rare tumor. So far only 10 patients (9 adults, 1 child) have been reported in the literature and all of them were treated with total splenectomy. Herein, we report the first infant case of the splenic hemangiopericytoma in a 10-month-old girl and the first case that was treated with partial splenectomy for splenic hemangiopericytoma.

Download full-text PDF

Source
http://dx.doi.org/10.3109/15513815.2012.656827DOI Listing

Publication Analysis

Top Keywords

splenic hemangiopericytoma
16
case treated
8
treated partial
8
partial splenectomy
8
splenectomy splenic
8
infantile splenic
4
hemangiopericytoma
4
hemangiopericytoma case
4
hemangiopericytoma rare
4
rare tumor
4

Similar Publications

Sclerosing angiomatoid nodular transformation (SANT) is a reactive non-neoplastic, rare vascular lesion of the spleen. The histology shows multiple angiomatoid nodules surrounded by proliferative stroma. A 31-year-old lady presented with an abdominal mass for 6 months.

View Article and Find Full Text PDF

Sclerosing angiomatoid nodular transformation (SANT) of the spleen: A case report on CT and MRI.

BJR Case Rep

June 2019

Department of Radiology, Fondazione IRCCS Istituto Nazionale Tumori Milan, Milan, Italy.

Solid tumors of the spleen are rare, with an incidence of 0.007% in all operating and autopsy specimens. In terms of microscopic structure and function, the spleen consists of two parts: the white pulp, which plays an important role in the immune system and the red pulp, which filters the blood.

View Article and Find Full Text PDF

Outcome and Prognostic Indicators for Hemangiopericytomas in Dogs: 167 Cases (2009-2016).

J Am Anim Hosp Assoc

January 2020

From the Surgery Department, Red Bank Veterinary Hospital, Tinton Falls, New Jersey (A.K., G.D.); and Department of Mathematics, Monmouth University, West Long Branch, New Jersey (R.P.B., K.F.).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!